Abstract:Ubiquitin-like proteins (UBLs) constitute a family of evolutionarily conserved proteins that share similarities with ubiquitin in 3D structures and modification mechanisms. For most UBLs including Small-Ubiquitin-like Modifiers (SUMO), their modification sites on substrate proteins cannot be identified using the mass spectrometry-based method that has been successful for identifying ubiquitination sites, unless a UBL protein is mutated accordingly. To identify UBL modification sites without having to mutate UBL, we have developed a dedicated search engine pLink-UBL on the basis of pLink, a software tool for identification of cross-linked peptide pairs. pLink-UBL exhibited superior precision, sensitivity, and speed than make-do search engines such as MaxQuant, pFind, and pLink. For example, compared to MaxQuant, pLink-UBL increased the number of identified SUMOylation sites by 50 ~ 300% from the same datasets. Additionally, we present a method for identifying small-molecule modifications of UBLs. This method involves antibody enrichment of a UBL C-terminal peptide following enrichment of a UBL protein, followed by LC-MS/MS analysis and a pFind 3 blind search to identify unexpected modifications. Using this method, we have discovered non-protein substrates of SUMO, of which spermidine is the major one for fission yeast SUMO Pmt3. Spermidine can be conjugated to the C-terminal carboxylate group of Pmt3 through its N1 or also likely, N8 amino group in the presence of SUMO E1, E2, and ATP. Pmt3-spermidine conjugation does not require E3 and can be reversed by SUMO isopeptidase Ulp1. SUMO-spermidine conjugation is present in mice and humans. Also, spermidine can be conjugated to ubiquitin in vitro by E1 and E2 in the presence of ATP. The above observations suggest that spermidine may be a common small molecule substrate of SUMO and possibly ubiquitin across eukaryotic species.

Conformational Dynamics and metal-ion interactions in human small Ubiquitin-like modifier (SUMO2)

Characterizing the Conformational Dynamics of Human SUMO2: Insights into its Interaction with Metal Ions and SIMs

The role of SUMOylation in biomolecular condensate dynamics and protein localization

Solution Structure of Human SUMO-3 C47S and Its Binding Surface for Ubc9,

SUMO conjugation – a mechanistic view

Structural analysis and evolution of specificity of the SUMO UFD E1-E2 interactions

Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation

Versatile protein tag, SUMO: Its enzymology and biological function

Platinum stabilises a molten‐globule conformation of a small globular cytosolic protein SUMO1

Probing Aromatic Side Chains Reveals the Site-Specific Melting in the SUMO1 Molten Globule

Q 7 A Progress in SUMO modification research

SUMO Interacting Motifs: Structure and Function

Insights into the Allosteric Inhibition of the SUMO E2 Enzyme Ubc9.

Signalling mechanisms and cellular functions of SUMO

Putative Role of Sumoylation in Controlling the Activity of Deubiquitinating Enzymes in Cancer

Chemical Protein Synthesis Combined with Protein Cell Delivery Reveals New Insights on the Maturation Process of SUMO2

Multifaceted roles of SUMO in DNA metabolism

Global analysis of protein and small-molecule substrates of ubiquitin-like proteins (UBLs)

SUMO’s intrinsically disordered N-terminus is an intramolecular inhibitor of SUMO - SIM interactions

A genome-wide analysis of sumoylation-related biological processes and functions in human nucleus.

SUMO-specific proteases and isopeptidases of the SENP family at a glance